{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:10:39Z","timestamp":1781575839629,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1124\/mol.118.114587","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T23:55:30Z","timestamp":1546991730000},"page":"324-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression"],"prefix":"10.1016","volume":"95","author":[{"given":"Kodye L.","family":"Abbott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe S.","family":"Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraswathi","family":"Vishveshwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Jiskrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Poulikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Vyhlidalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyanarayana R.","family":"Pondugula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.118.114587_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00280-016-3167-7","article-title":"A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors","volume":"78","author":"Bailey","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/mol.118.114587_bib2","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.3390\/molecules18077389","article-title":"Modulation of xenobiotic receptors by steroids","volume":"18","author":"Banerjee","year":"2013","journal-title":"Molecules"},{"key":"10.1124\/mol.118.114587_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12248-009-9146-8","article-title":"Herb-drug interactions with St John\u2019s wort (Hypericum perforatum): an update on clinical observations","volume":"11","author":"Borrelli","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/mol.118.114587_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10637-015-0321-8","article-title":"Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignancies","volume":"34","author":"Calvo","year":"2016","journal-title":"Invest New Drugs"},{"key":"10.1124\/mol.118.114587_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbagrm.2016.02.013","article-title":"Small-molecule modulators of PXR and CAR","volume":"1859","author":"Chai","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.118.114587_bib6","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/pro.3012","article-title":"Exploration of the conformational landscape in pregnane X receptor reveals a new binding pocket","volume":"25","author":"Chandran","year":"2016","journal-title":"Protein Sci"},{"key":"10.1124\/mol.118.114587_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/03602530600569828","article-title":"Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR)","volume":"38","author":"Chang","year":"2006","journal-title":"Drug Metab Rev"},{"key":"10.1124\/mol.118.114587_bib8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.bcp.2012.01.030","article-title":"Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters","volume":"83","author":"Chen","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.118.114587_bib9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1124\/dmd.115.063743","article-title":"Use of transgenic mouse models to understand the oral disposition and drug-drug interaction potential of cobimetinib, a MEK inhibitor","volume":"43","author":"Choo","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.118.114587_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bcp.2008.06.016","article-title":"Application and interpretation of hPXR screening data: validation of reporter signal requirements for prediction of clinically relevant CYP3A4 inducers","volume":"76","author":"Cui","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.118.114587_bib11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/03602532.2010.484462","article-title":"Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids","volume":"42","author":"Dvorak","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/mol.118.114587_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0090-9556(24)15091-X","article-title":"Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: role of the glucocorticoid and pregnane X receptors","volume":"28","author":"El-Sankary","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.118.114587_bib13","unstructured":"Food and Drug Administration (2014) Beleodaq (belinostat) for injection, in Approved Drug Products with Therapeutic Equivalence Evaluations. Food and Drug Administration, White Oak, MD."},{"key":"10.1124\/mol.118.114587_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/138920007779815995","article-title":"A mechanistic study on altered pharmacokinetics of irinotecan by St. John\u2019s wort","volume":"8","author":"Hu","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1124\/mol.118.114587_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/sj.onc.1209788","article-title":"Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole","volume":"26","author":"Huang","year":"2007","journal-title":"Oncogene"},{"key":"10.1124\/mol.118.114587_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J Mol Biol"},{"key":"10.1124\/mol.118.114587_bib17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1634\/theoncologist.2017-0524","article-title":"Recent advances in the treatment of peripheral T-cell lymphoma","volume":"23","author":"Laribi","year":"2018","journal-title":"Oncologist"},{"key":"10.1124\/mol.118.114587_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.bjc.6605726","article-title":"A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and\/or paclitaxel in patients with solid tumours","volume":"103","author":"Lassen","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1124\/mol.118.114587_bib19","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1124\/dmd.110.035501","article-title":"Metabolism and action of proteasome inhibitors in primary human hepatocytes","volume":"38","author":"Lee","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.118.114587_bib20","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","article-title":"FDA approval: belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma","volume":"21","author":"Lee","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.118.114587_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.steroids.2016.02.019","article-title":"New dimension of glucocorticoids in cancer treatment","volume":"111","author":"Lin","year":"2016","journal-title":"Steroids"},{"key":"10.1124\/mol.118.114587_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-017-00780-5","article-title":"SPA70 is a potent antagonist of human pregnane X receptor","volume":"8","author":"Lin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/mol.118.114587_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/dmd.30.7.795","article-title":"CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes","volume":"30","author":"Luo","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.118.114587_bib24","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1158\/0008-5472.CAN-15-1454","article-title":"Activation status of the pregnane X receptor influences vemurafenib availability in humanized mouse models","volume":"75","author":"MacLeod","year":"2015","journal-title":"Cancer Res"},{"key":"10.1124\/mol.118.114587_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/03602532.2012.746363","article-title":"PXR antagonists and implication in drug metabolism","volume":"45","author":"Mani","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1124\/mol.118.114587_bib26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-0463.2008.00957.x","article-title":"Monitoring the effect of belinostat in solid tumors by H4 acetylation","volume":"116","author":"Marquard","year":"2008","journal-title":"APMIS"},{"key":"10.1124\/mol.118.114587_bib27","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/me.2004-0434","article-title":"The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion","volume":"19","author":"Masuyama","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.118.114587_bib28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jcph.510","article-title":"Pharmacokinetic (PK) drug interaction studies of cabozantinib: effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK","volume":"55","author":"Nguyen","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/mol.118.114587_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0026-895X(24)12072-X","article-title":"Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators","volume":"58","author":"Pascussi","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.114587_bib30","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1046\/j.0014-2956.2001.02540.x","article-title":"Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor","volume":"268","author":"Pascussi","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1124\/mol.118.114587_bib31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1310\/hpj4911-1009","article-title":"Drug monographs: belinostat and idelalisib","volume":"49","author":"Piper","year":"2014","journal-title":"Hosp Pharm"},{"key":"10.1124\/mol.118.114587_bib32","doi-asserted-by":"crossref","first-page":"56558","DOI":"10.18632\/oncotarget.10646","article-title":"Pregnane X-receptor promotes stem cell-mediated colon cancer relapse","volume":"7","author":"Planque","year":"2016","journal-title":"Oncotarget"},{"key":"10.1124\/mol.118.114587_bib33","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bbrc.2015.03.141","article-title":"Stearidonic acid, a plant-based dietary fatty acid, enhances the chemosensitivity of canine lymphoid tumor cells","volume":"460","author":"Pondugula","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.118.114587_bib34","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.toxlet.2014.12.015","article-title":"Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR","volume":"232","author":"Pondugula","year":"2015","journal-title":"Toxicol Lett"},{"key":"10.1124\/mol.118.114587_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1124\/dmd.114.062083","article-title":"Mg2+\/Mn2+-dependent phosphatase 1A is involved in regulating pregnane X receptor-mediated cytochrome p450 3A4 gene expression","volume":"43","author":"Pondugula","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.118.114587_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.08.030","article-title":"Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response","volume":"328","author":"Pondugula","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1124\/mol.118.114587_bib37","doi-asserted-by":"crossref","DOI":"10.11131\/2016\/101198","article-title":"Pregnane X receptor and cancer: context-specificity is key","volume":"3","author":"Pondugula","year":"2016","journal-title":"Nucl Receptor Res"},{"key":"10.1124\/mol.118.114587_bib38","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40265-014-0275-8","article-title":"Belinostat: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1124\/mol.118.114587_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2012.10.029","article-title":"Sulforaphane is not an effective antagonist of the human pregnane X-receptor in vivo","volume":"266","author":"Poulton","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/mol.118.114587_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2045-3701-4-17","article-title":"Tissue-specific regulation of pregnane X receptor in cancer development and therapy","volume":"4","author":"Robbins","year":"2014","journal-title":"Cell Biosci"},{"key":"10.1124\/mol.118.114587_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/mol.62.3.439","article-title":"Development of a real-time in vivo transcription assay: application reveals pregnane X receptor-mediated induction of CYP3A4 by cancer chemotherapeutic agents","volume":"62","author":"Schuetz","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.114587_bib42","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/1078-0432.CCR-07-1786","article-title":"A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumors","volume":"14","author":"Steele","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.118.114587_bib43","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/87912","article-title":"The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux","volume":"7","author":"Synold","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/mol.118.114587_bib44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/toxsci\/kfr178","article-title":"Acetyl tributyl citrate, the most widely used phthalate substitute plasticizer, induces cytochrome p450 3a through steroid and xenobiotic receptor","volume":"123","author":"Takeshita","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1124\/mol.118.114587_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/mol.65.1.36","article-title":"Identification of amino acids in rat pregnane X receptor that determine species-specific activation","volume":"65","author":"Tirona","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.114587_bib46","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jcc.24523","article-title":"On the importance of composite protein multiple ligand interactions in protein pockets","volume":"38","author":"Tonddast-Navaei","year":"2017","journal-title":"J Comput Chem"},{"key":"10.1124\/mol.118.114587_bib47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nbt.1581","article-title":"Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries","volume":"27","author":"Veith","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1124\/mol.118.114587_bib48","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/dmd.31.5.620","article-title":"Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes","volume":"31","author":"Wang","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.118.114587_bib49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bcp.2010.12.003","article-title":"Evaluation of in vitro PXR-based assays and in silico modeling approaches for understanding the binding of a structurally diverse set of drugs to PXR","volume":"81","author":"Xiao","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.118.114587_bib50","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1200\/JCO.2011.41.2395","volume":"30","author":"Yeo","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1124\/mol.118.114587_bib51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.106.029264","article-title":"The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor","volume":"71","author":"Zhou","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.114587_bib52","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/dmd.116.072124","article-title":"Evaluation of a novel renewable hepatic cell model for prediction of clinical CYP3A4 induction using a correlation-based relative induction score approach","volume":"45","author":"Zuo","year":"2017","journal-title":"Drug Metab Dispos"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.118.114587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:28:09Z","timestamp":1739960889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24008708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0026895X24008708"],"URL":"https:\/\/doi.org\/10.1124\/mol.118.114587","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.118.114587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}